Ordinary Re-Weighting | DER AKTIONÄR BIOTECH SUPERTRENDS INDEX | Effective Date 3rd April 2024
DER AKTIONÄR BIOTECH SUPERTRENDS INDEX:
In the ordinary re-weighting, the following composition will be implemented effective open 3rd April 2024:
ARROWHEAD PHARMACEUTICALS INC |
BIONTECH SE |
BLUEPRINT MEDICINES CORP |
CRISPR THERAPEUTICS AG |
DENALI THERAPEUTICS INC |
ECKERT & ZIEGLER STRAHLEN UND MEDIZINTECHNIK AG |
ILLUMINA INC |
IMMUNOCORE HOLDINGS PLC |
INTUITIVE SURGICAL INC |
MADRIGAL PHARMACEUTICALS INC |
SWEDISH ORPHAN BIOVITRUM AB |
VIKING THERAPEUTICS INC |
VOYAGER THERAPEUTICS INC |